About Emcay
Emcay is a Healthcare company based in New York (United States) founded in 2013, and was acquired by Fingerpaint in July 2022. Provider of branding, digital marketing, and advertising services for pharmaceutical sector. Emcay offers products and services including Branding Services, Medical Communications, and Medical Affairs. Its focus areas include Biopharma Outsourcing and Marketing Services. Its competitors include Zevra, Supreme Optimization and Woodward Pharma Services.
Company details
Emcay was established in 2013 and is based in New York, United States. Operations focus on the pharmaceutical sector, where branding, digital marketing, and advertising services are delivered. These services support client needs in promotional strategies and online presence. The company operates through its domain emcay.net, serving businesses in this specialized industry across relevant geographies.
- Headquarters New York, United States
- Stage Acquired
- SectorsHealthcare
- Website emcay.net
- Social LinkedIn
- Acquired by Fingerpaint (Jul 2022)
- Investors
- Acquired byFingerpaint
(Jul 2022)
Products & Services of Emcay
Emcay offers a comprehensive portfolio of products and services, including Branding Services, Medical Communications, and Medical Affairs.
Offers strategic branding for healthcare through naming and design.
Provides communications expertise for pharmaceutical industry needs.
Delivers omnichannel engagement strategies for medical sectors.
Investors in Emcay
Emcay has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fingerpaint.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare information and content are delivered through an online platform. | 2008 | fingerpaint.com | Saratoga Springs, United States |
Investor details for Emcay
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Emcay
2 dated milestones of Emcay across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Emcay is founded.
- Exit Acquired by Fingerpaint.
Competitors of Emcay
Emcay has 3 listed competitors in our database. They include Zevra, Supreme Optimization and Woodward Pharma Services.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zevra.com | 2006 | Celebration, United States | 45 | Marketing services are provided to biopharma companies. | ||
| supremeopti.com | 2012 | San Juan, Puerto Rico | Digital marketing services are offered to the life sciences sector. | |||
| woodwardpharma.com | 2015 | Wixom, United States | Pharmaceutical company that provides outsourced marketing, sales, and commercial services for pharmaceutical companies |
Detailed competitors of Emcay
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Emcay (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Emcay
Complete news archive for Emcay
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emcay
Emcay was founded in 2013.
Emcay is headquartered in New York, United States. It is registered at New York, New York, United States.
Emcay was established in 2013 and is based in New York, United States. Operations focus on the pharmaceutical sector, where branding, digital marketing, and advertising services are delivered. These services support client needs in promotional strategies and online presence. The company operates through its domain emcay.net, serving businesses in this specialized industry across relevant geographies.
Emcay's top competitors include Zevra, Supreme Optimization and Woodward Pharma Services.
Emcay offers Branding Services, Medical Communications, and Medical Affairs.
Emcay has 1 investor. Key investors include Fingerpaint.
Yes. Emcay was acquired by Fingerpaint in July 2022.

